The aim of this study is to investigate the influence on the quality of life and sexual function before, 6 month and one year after Novasure Endometrial Ablation in the treatment of Menorrhagia.

patients diagnosed menorrhagia scheduled for Novasure Endometrial Ablation because of menorrhagia between november, 2012 and november, 2014 are enrolled to this study.

patients are asked to complete preoperative questionnaires considering Health Related Quality of Life questionnaire(HRQoL) and sexual Female Sexual Functioning Index questionnaire(FSFI). Same questionnaires will also be completed six months and one year after operation.

Inclusion Criteria:

• clinical diagnosis of menorrhagia
• family complete
• normal endometrial pathology
• had not been referred specifically for surgery
• with normal uterine cavity

Exclusion Criteria:

• pregnancy or demand to preserve fertility
• acute reproductive tract inflammation or urinary tract inflammation
• pathology demonstrate endometrial cancer or precancerous change
• acute pelvic inflammation
• intrauterine device(IUD) in uterus
• depth of uterine cavity less than 4cm or more than 10cm
• pathologic myometrium( such as history of Hysteromyomectomy or classical cesarean section)

100 patients diagnosed menorrhagia scheduled for Novasure endometrial ablation in The First Affiliated Hospital between November 2012 and November 2015